Skip to main content
. 2021 Nov 2;13:8241–8255. doi: 10.2147/CMAR.S329963

Table 4.

Multivariate Cox Analyses of PFS and OS

A. NLR and STM Multivariate Cox Analysis PFS OS
HR (95% CI) P HR (95% CI) P
Radiotherapy Yes vs No 1.079 (0.432–2.691) 0.871 0.843 (0.342–2.078) 0.710
Mono-immunotherapy Yes vs No 1.786 (0.758–4.212) 0.185 / /
Leading STM change Decrease <20% vs Decrease ≥20% 2.892 (0.976–8.568) 0.055 0.510 (0.193–1.350) 0.175
Pretreatment NLR ≥5 vs <5 / / 0.805 (0.308–2.099) 0.657
Posttreatment NLR ≥5 vs <5 0.144 (0.048–0.427) 0.001 0.122 (0.042–0.352) 0.001
B. The Combination Score Multivariate Cox Analysis PFS OS
HR (95% CI) P HR (95% CI) P
Radiotherapy Yes vs No 1.049 (0.417–2.643) 0.919 0.807 (0.329–1.976) 0.630
Mono-immunotherapy Yes vs No 1.860 (0.772–4.480) 0.167 / /
Combination Score 0
1 3.661 (1.136–11.792) 0.030 3.183 (1.02–9.931) 0.046
2 20.066 (5.646–71.311) <0.0001 22.299 (6.381–77.924) <0.0001

Notes: Cox regression models were applied to find independent indicators associated with PFS and OS and estimate the hazard ratio (HR). Factors which were statistically significant in the univariate analysis were incorporated into the multivariate analysis. Figures are given as HR (95% CI). A P value of < 0.05 was regarded statistically significant.

Abbreviations: PFS, progression-free survival; OS, overall survival; HR: hazard ratio; CI, confidence interval.